Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Corticosteroid Treatment for Post-COVID-19 Persistent Interstitial Lung Disease

NCT07380152 is registered in ClinicalTrials.gov with University of Sao Paulo as lead sponsor.

NCT NCT07380152
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07380152 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Corticosteroid Treatment for Post-COVID-19 Persistent Interstitial Lung Disease
Lead sponsor
University of Sao Paulo
Phase
Phase 1
Overall status
Completed
Start date
August 10, 2021
Completion date
December 12, 2022
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19 pulmonary complications